Related Experiment Video
Updated: Jun 23, 2025
06:18
An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
12.2K
Estrogen-immuno-neuromodulation disorders in menopausal depression
Yuling Zhang1, Xiying Tan2, Chaozhi Tang3
1College of Life Science, Henan Normal University, Xinxiang, 453007, Henan, China.
Journal of Neuroinflammation
|June 19, 2024
Summary
Menopausal depression is linked to decreased estrogen and immune imbalance. Targeting inflammation and specific signaling pathways may offer new treatments for this condition.
Area of Science:
- Neuroendocrinology
- Immunology
- Reproductive Biology
Background:
- Menopause-associated estrogen decline increases major depression risk.
- Immune dysregulation and elevated inflammation are observed in menopausal depression.
Purpose of the Study:
- To investigate the mechanisms of immune imbalance due to estrogen deficiency in menopause.
- To explore the role of estrogen-immuno-neuromodulation in menopausal depression.
Main Methods:
- Examined estrogen's effects on immune homeostasis and inflammatory cytokines.
- Analyzed signaling pathways including ERα/ERβ/GPER-associated NLRP3/NF-κB.
- Investigated impacts on blood-brain barrier, neurotransmitters, BDNF, and neuroplasticity.
Main Results:
- Estrogen deficiency disrupts immune homeostasis and inflammatory cytokine levels via specific pathways.
- Inflammatory cytokines contribute to blood-brain barrier damage, neurotransmitter dysfunction, and reduced neuroplasticity.
- Estrogen-immuno-neuromodulation disorders are implicated in menopausal depression.
Conclusions:
- Estrogen deficiency significantly impacts immune and neural systems in menopausal depression.
- Targeting inflammatory cytokines and NLRP3/NF-κB pathways shows therapeutic potential.
- Restoring system homeostasis may improve menopausal depression intervention and treatment.
Keywords:
BDNFBlood-brain barrierEstrogenInflammatory cytokineMenopausal depressionNeuroplasticityNeurotransmitterMore Related Videos
Related Concept Videos
01:28Menopause
154
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
154
01:24Disorders of the Female Reproductive System
347
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
347
01:23Antidepressant Drugs: MAOIs and Other Agents
220
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
220
01:22Hormonal Regulation of the Menstrual Cycle
339
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
339
01:18Depression: Overview
238
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
238
01:20Disorders of the Male Reproductive System
386
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
386